Taixian Li

Disease-Modifying Anti-rheumatic Drug Prescription Baihu-Guizhi Decoction Attenuates Rheumatoid Arthritis via Suppressing Toll-Like Receptor 4-mediated NLRP3 Inflammasome Activation

Weijie Li, Xia Mao, Xiaoyue Wang et al. · Frontiers in Pharmacology · 2021 · 51 citations · Full text

Deciphering the chemical profile and pharmacological mechanisms of Baihu-Guizhi decoction using ultra-fast liquid chromatography-quadrupole-time-of-flight tandem mass spectrometry coupled with network pharmacology-based investigation

Weijie Li, Xia Mao, Hao Wu et al. · Phytomedicine · 2019 · 49 citations

Biochemistry, Traditional Chinese Medicine, Medicine +11

Discovery and validation an eight-biomarker serum gene signature for the diagnosis of steroid-induced osteonecrosis of the femoral head

Taixian Li, Yanqiong Zhang, Rongtian Wang et al. · Bone · 2019 · 46 citations

Bone Disease, Rheumatology, Osteoarthritis +10

A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation

Yanqiong Zhang, Xia Mao, Wenjia Chen et al. · Molecular Therapy — Nucleic Acids · 2020 · 45 citations · Full text

Inferences of individual differences in response to tripterysium glycosides across patients with Rheumatoid arthritis using a novel ceRNA regulatory axis

Yanqiong Zhang, Xiaoyue Wang, Weijie Li et al. · Clinical and Translational Medicine · 2020 · 20 citations · Full text